King Street Properties and development partner GFP Real Estate today said that Innolabs in Long Island City has reached full occupancy following the signing of a 15,763-square-foot lease with Rover Diagnostics. Rover Diagnostics will occupy a ground-floor, pre-built lab suite at the 267,000-square-foot lab property.
“Achieving full occupancy at Innolabs is a reflection of the quality of our building and the continued need for flexible, ready-to-go lab environments,” said Ed Jaram, senior director at King Street. “Companies like Rover Diagnostics exemplify the type of innovative companies Innolabs was designed to support – those advancing critical work and seeking space that allows them to hit the ground running.”
Rover Diagnostics is a leader in point-of-care PCR diagnostics, with a focus on advancing women’s health through accessible, rapid testing solutions. The transaction was brokered by Tom Burrus of JLL on behalf of Rover Diagnostics, and Bill Harvey and John Cahill of JLL on behalf of ownership.
